Business
Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – October 3, 2024  ...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n LONDON, Ontario; BOSTON,\nMassachusetts –\n \n\n October 3,\n2024\n \n\n – TheNewswire – Sernova Corp. (TSX:SVA)\n(OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company\nfocused on the development of regenerative medicine cell therapies for\ntreatment of chronic diseases,\n \n\n announced that\nits CEO, Jonathan Rigby, will be presenting at the 2024 Cell &\nGene Meeting on the Mesa being held October 7-9, 2024, at the Arizona\nBiltmore Hotel in Phoenix, Arizona. The Cell & Gene Meeting on the\nMesa is the sector’s foremost annual conference bringing together\nsenior executives and top decision-makers in the industry to advance\ncutting-edge research into cell therapy cures.\n \n\n\n Mr. Rigby’s presentation is scheduled to begin at 10:00 A.M. MT\n(12:00 P.M. ET) on Monday, October 7, 2024. The presentation will\ninclude updates on Sernova’s type 1 diabetes phase 1/2 clinical\ntrial at the University of Chicago, and its pre-clinical work with\nEvotec to advance a potential iPSC-based (induced pluripotent stem\ncell) islet replacement therapy with Sernova’s  Cell Pouch™\nTransplant System.\n \n\n\n ABOUT SERNOVA AND ITS CELL POUCH™\nTRANSLPLANT SYSTEM PLATFORM FOR CELL THERAPY\n \n\n\n\n Sernova Corp. is a clinical-stage biotechnology company\nthat is developing therapeutic cell technologies for chronic diseases,\nincluding insulin-dependent diabetes, thyroid disease, and blood\ndisorders that include hemophilia A. Sernova is currently focused on\ndeveloping a ‘functional cure’ for insulin-dependent diabetes with\nits lead technology, the Cell Pouch Transplant System, a novel\nimplantable and scalable medical device with immune protected\ntherapeutic cells.\n \n\n\n\n On implantation, The Cell Pouch forms a natural,\nvascularized tissue environment in the body allowing long-term\nsurvival and function of therapeutic cells that release essential\nfactors that are absent or deficient in patients with certain chronic\ndiseases. Sernova’s Cell Pouch Transplant System has demonstrated\nits potential to be a ‘functional cure’ for people with T1D in an\nongoi...